Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Bayer Aktienges ADR (OP:BAYRY)

8.020 +0.060 (+0.75%)
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 333,953
Open 8.030
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 7.960
Today's Range 7.980 - 8.050
52wk Range 4.790 - 8.700
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bayer’s Lynkuet® (elinzanetant), the First and Only Neurokinin 1 and Neurokinin 3 Receptor Antagonist, Receives FDA Approval for Moderate to Severe Hot Flashes Due to Menopause
From Bayer
Via Business Wire
Top 3 Health Care Stocks You'll Regret Missing In October
 
Via Benzinga

Performance

YTD
+62.3%
+62.3%
1 Month
-0.6%
-0.6%
3 Month
-6.3%
-6.3%
6 Month
+21.3%
+21.3%
1 Year
+14.9%
+14.9%

More News

Read More
Late-breaking data from Phase III OCEANIC-STROKE study accepted for presentation at World Stroke Congress 2025
From Bayer
Via Business Wire
Exelixis Stock Falls After Phase 3 Colorectal Cancer Trial Shows Mixed Results
Via Benzinga
Bayer Partners with Cornfed Farms to Create First ForwardFarm in Midwest
From Bayer
Via Business Wire
One A Day® Unveils Bold New Brand Identity and Platform: “The ONE for you”
From Bayer
Via Business Wire
BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinson’s disease
From Bayer
Via Business Wire
Bayer Selects Interpublic as Global Media, Production and Creative Agency Partner for Consumer Health Division
From Bayer
Via Business Wire
Bayer to Highlight New Data for KERENDIA® (finerenone) at Heart Failure Society of America (HFSA) Annual Scientific Meeting 2025
From Bayer
Via Business Wire
Bayer First Company to Advance Cell Therapy as Well as Gene Therapy Against Parkinson’s Disease
From Bayer
Via Business Wire
10 Years of Supporting Rural America: Bayer and Luke Bryan Team Up with Feeding America® to Tackle Hunger with “Take Care, Now” Campaign
From Bayer
Via Business Wire
Agri-Science Giant Corteva Eyes Breakup To Shield Seed Unit From Future Risks: Report
Via Benzinga
Gadoquatrane New Drug Application Accepted for Review by U.S. FDA
From Bayer
Via Business Wire
Monsanto Reaches Agreements in Principle to Resolve Additional PCB Cases at the Sky Valley Education Center
From Bayer
Via Business Wire
Bayer® Aspirin Introduces Aspirina to the U.S. Pain Market
From Bayer
Via Business Wire
Retail Turns Bearish On Bayer After $1.3B Kumquat Cancer Drug Deal
Via Stocktwits
OTC Markets Group Announces Quarterly Index Performance and Rebalancing
From OTC Markets
Via GlobeNewswire
U.S. Current-Account Deficit Widens to $450 Billion Amid Trade Imbalances and Energy Imports
Via MarketMinute
Topics Artificial Intelligence Economy Supply Chain
History of Recursion Pharmaceuticals, Inc.: AI‑Driven Drug Discovery Beginnings (NASDAQ:RXRX)
Via MarketMinute
Topics Artificial Intelligence
Exelixis' Zanzalintinib Combo Boosts Survival In Colorectal Cancer, Stock Soars
Via Benzinga
Exelixis Catapults 14% On Positive Results For Next-Gen Colon Cancer Drug
Via Investor's Business Daily
OTC Markets Group Welcomes Bayer AG to OTCQX
From OTC Markets
Via GlobeNewswire
Bayer Profit Drops 35%, Launches Overhaul To Counter Generic Pressure
Via Benzinga
FDA Grants Complete Approval To Bayer's Drug For Certain Type Cancer With Mutation
Via Benzinga
Bayer Enters License Agreement With China’s Puhe BioPharma For Cancer Drug Candidate: Retail Stays Bullish
Via Stocktwits

Frequently Asked Questions

Is Bayer Aktienges ADR publicly traded?
Yes, Bayer Aktienges ADR is publicly traded.
What exchange does Bayer Aktienges ADR trade on?
Bayer Aktienges ADR trades on the OTC Traded
What is the ticker symbol for Bayer Aktienges ADR?
The ticker symbol for Bayer Aktienges ADR is BAYRY on the OTC Traded
What is the current price of Bayer Aktienges ADR?
The current price of Bayer Aktienges ADR is 8.020
When was Bayer Aktienges ADR last traded?
The last trade of Bayer Aktienges ADR was at 10/24/25 03:59 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.